These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 38202644)
1. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells. Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644 [TBL] [Abstract][Full Text] [Related]
2. Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells. Ahmed SA; Mendonca P; Messeha SS; Soliman KFA Molecules; 2023 Sep; 28(18):. PubMed ID: 37764312 [TBL] [Abstract][Full Text] [Related]
3. Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, Angiogenesis Inhibition, and Autophagy Modulation. Ahmed SA; Mendonca P; Elhag R; Soliman KFA Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555740 [TBL] [Abstract][Full Text] [Related]
4. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
5. Involvement of AKT/PI3K Pathway in Sanguinarine's Induced Apoptosis and Cell Cycle Arrest in Triple-negative Breast Cancer Cells. Messeha SS; Noel S; Zarmouh NO; Womble T; Latinwo LM; Soliman KFA Cancer Genomics Proteomics; 2023; 20(4):323-342. PubMed ID: 37400144 [TBL] [Abstract][Full Text] [Related]
6. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells. Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203 [TBL] [Abstract][Full Text] [Related]
9. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway. Xu Y; Fang R; Shao J; Cai Z Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34036307 [TBL] [Abstract][Full Text] [Related]
10. Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway. Jin Y; Qiu S; Shao N; Zheng J Med Sci Monit; 2018 Jan; 24():11-18. PubMed ID: 29291370 [TBL] [Abstract][Full Text] [Related]
11. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway. Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857 [TBL] [Abstract][Full Text] [Related]
12. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway. Qu J; Sun Y; Yang L; Niu X; Li L J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250 [TBL] [Abstract][Full Text] [Related]
13. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway. Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381 [TBL] [Abstract][Full Text] [Related]
14. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells. Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA Nutrients; 2022 May; 14(10):. PubMed ID: 35631261 [TBL] [Abstract][Full Text] [Related]
15. Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer. Van Swearingen AED; Sambade MJ; Siegel MB; Sud S; McNeill RS; Bevill SM; Chen X; Bash RE; Mounsey L; Golitz BT; Santos C; Deal A; Parker JS; Rashid N; Miller CR; Johnson GL; Anders CK Neuro Oncol; 2017 Oct; 19(11):1481-1493. PubMed ID: 28486691 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
17. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling. Cheng W; Liu D; Guo M; Li H; Wang Q Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453 [TBL] [Abstract][Full Text] [Related]
18. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563 [TBL] [Abstract][Full Text] [Related]
19. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. Wu C; Qiu S; Liu P; Ge Y; Gao X J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890 [TBL] [Abstract][Full Text] [Related]
20. Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy. Zhang S; Cui T; Duan Y; Zhang H; Wang B; Chen H; Ni J; Shen Y; Xiao-Ai Lv Clin Breast Cancer; 2022 Feb; 22(2):89-97. PubMed ID: 34535390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]